Skip to content

PANDA-S: Prognostic AND Diagnostic Assessment of Shoulder pain

Maximising outcome for patients with shoulder pain: using optimal diagnostic and prognostic information to target treatment (PANDA-S)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN46948079
Enrollment
471
Registered
2018-11-30
Start date
2019-02-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder pain Musculoskeletal Diseases Shoulder pain

Interventions

Participants will be invited to take part in the cohort study and be followed-up over a period of three years with questionnaires mailed at baseline (shortly after consulting their GP or physiotherapi

Sponsors

University of Keele
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Registered at participating general practices or attending participating self-referral physiotherapy services 2. Aged 18 years or over 3. Presenting with a new episode of shoulder-related pain (defined as no shoulder-related consultation, no injection, surgery, or physiotherapy-led exercise for shoulder pain, in the last 6 months)

Exclusion criteria

Exclusion criteria: 1. Present to the GP or physiotherapist with symptoms or signs indicative of serious pathology (e.g. fractures, infection), have shoulder pain caused by stroke-related subluxation 2. Diagnosis of inflammatory arthritis, including rheumatoid arthritis, and polymyalgia rheumatica 3. Shoulder pain caused by cervical pathology 4. Considered by the GP or physiotherapist to be vulnerable (severe physical and/or mental health problems, dementia) 5. Unable to complete written questionnaires in English

Design outcomes

Primary

MeasureTime frame
Pain and disability, assessed using the Shoulder Pain and Disability Questionnaire (SPADI) at baseline and 6 months

Secondary

MeasureTime frame
The following are assessed at the baseline and after 3, 6, 12, 24, 36 months: 1. Pain (worst pain in the past week), assessed using a numerical rating scale (0-10) 2. Sleep, assessed using the Jenkins Sleep Evaluation Questionnaire (JSEQ) 3. Global perceived change in shoulder pain since baseline assessed using a single question "Compared to when you completed your last questionnaire X months ago how would you say your shoulder pain is now?". The answer is selected from "Completely recovered, much improved, somewhat improved, same, somewhat worse, much worse". 4. Work absence, assessed by: 4.1. Participant report of current absence (days/weeks/months) 4.2. Analysis of medical records (where there is consent to access) 5. Work performance, assessed using: 5.1. Response to question "question "If your work has been affected, on average, to what extent has shoulder pain affected your performance at work in the past 1 month?" using numerical rating scale (0-10, where 0 is not at all to 10 is the pain is so bad I have been unable to do my job) 5.2. Number of days work performance affected by pain assessed using question "Not including absence from work, on how many days in the last month has your work been affected by your shoulder pain?" 6. Health status, assessed using the EQ-5D-5L

Countries

England, United Kingdom

Contacts

Public ContactDanielle van der Windt
d.van.der.windt@keele.ac.uk01782 734830

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026